Electrokinetic dispersion of a cancer chemotherapeutic drug for the treatment of solid tumours

Cancer Letters

Volumn 279, Issue 2, 2009, Pages 202-208

  Nomikou, Nikolitsa ^a   McHale, Anthony P ^a  

^a UNIVERSITY OF ULSTER   (United Kingdom)

Author keywords

Camptothecin; Cancer; Chemotherapeutic; EChT; Lung

Indexed keywords

ANTINEOPLASTIC AGENT; CAMPTOTHECIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CHEMOTHERAPY; CANCER TISSUE; CONTROLLED STUDY; DIRECT CURRENT; DRUG DISTRIBUTION; DRUG EFFECT; DRUG INDICATION; DRUG TRANSPORT; ELECTRIC FIELD; FIBROSARCOMA; LUNG CANCER; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; SOLID TUMOR; TUMOR LOCALIZATION;

ANIMALS; ANTINEOPLASTIC AGENTS; CAMPTOTHECIN; CELL LINE, TUMOR; CELL SURVIVAL; DRUG DELIVERY SYSTEMS; ELECTROMAGNETIC FIELDS; FIBROSARCOMA; MICE; NEOPLASM TRANSPLANTATION; RATS;

EID: 67349173935     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2009.01.038     Document Type: Article

References (25)

1. Wu J., Akaiki T., and Maeda H. Modulation of enhanced vascular permeability in tumours by a bradykinin antagonist, a cyclooxygenase inhibitor and a nitric oxide scavenger. Cancer Res. 58 (1998) 159-165
2. Heldin C.H., Rubin K., Peitras K., and Ostman A. High interstitial fluid pressure - an obstacle in cancer therapy. Nature Rev. 4 (2004) 806-813
3. Hassad Y., Eyal E., Margalit R., Furman-Haran E., and Degani H. Non-invasive imaging of barriers to drug delivery in tumours. Microvascular Res. 76 (2008) 94-103
4. Grootenboers M.J., Heeren J., van Putte B.P., Hendriks J.M.H., van Boven W.J., van Schil P.E.Y., and Schramel F.M.N.H. Isolated lung perfusion for pulmonary metastases, a review and work in progress. Perfusion 21 (2006) 267-276
5. Muchmore J.H., and Wanebo H.J. Regional chemotherapy - an overview. Surg. Oncol. Clin. N. Am. 17 (2008) 709-730
6. Flynn G., McHale L., and McHale A.P. Methotrexate-loaded, photosensitised erythrocytes: a photoactivatable carrier/delivery system for use in cancer therapy. Cancer Lett. 82 (1994) 225-229
7. Li Y.S., Reid C.N., and McHale A.P. Enhancing ultrasound-mediated cell membrane permeability (sonoporation) using a high frequency pulse regime and implications for ultrasound-aided cancer chemotherapy. Cancer Lett. 266 (2008) 156-162
8. Corovic S., Al Sakere B., Haddad V., Miklavcic D., and Mir L.M. Importance of contact surface between electrodes and treated tissue in electrochemotherapy. Technol. Cancer Res. Treat. 7 (2008) 393-400
9. Pasterino F., Di Paolo D., Piccardi F., Nico B., Ribatti D., Daga A., Baio G., Neumaier C.E., Brignole C., Loi M., Marimpeitri D., Pagnan G., Cilli M., Lepekhin E.A., Garde S.V., Longhi R., Corti A., Allen T.M., Wu J.J., and Ponzoni M. Enhanced antitumour efficacy of clinical grade vasculature-targeted liposomal doxorubicin. Clin. Cancer Res. 14 (2008) 7320-7329
10. M. Tello, L. Oliveiri, O. Parise, A.C. Buzaid, R.T. Oliveiri, R. Zanalla, A. Cardona, Electrochemical therapy to treat cancer (in vivo treatment), in: Proceedings of the Twenty-nine Annual International Conference on IEEE EMBS, 2007, pp. 3524-3527.
11. von Euler H., Soderstedt A., Thorne A., Olssen J.M., and Yongqing G. Cellular toxicity induced by pH levels on the R323AC rat mammary tumour cell line. An in vitro model for the investigation of the tumour destructive properties of electrochemical treatment of tumours. Bioelectrochemistry 58 (2002) 163-170
12. Ren R.L., Vora N., Yang F., Longmate J., Wang W., Sun H., Li J.R., Weiss L., Staud C., McDougall J.A., and Chou C.K. Variations of dose and electrode spacing for rat breast cancer electrochemical treatment. Bioelectromagnetics 22 (2001) 205-211
13. Nomikou N., and McHale A.P. Electro-biosorptive accumulation for use in enhanced detection of fluorogenic tracers and the removal of toxic entities from dilute solutions. Biotechnol. Lett. 29 (2007) 561-567
14. Lalloo A.K., Luo F.R., Guo A., Paranjpe P.V., Lee S.H., Vyas V., Rubin E., and Sinko P.J. Membrane transport of camptothecin: facilitation of human P-glycoprotein (ABCB1) and multidrug resistance protein 2 (ABCC2). BMC Med. 2 (2004) 16
15. Schlichenmyer W.J., Rowinsky E.K., Donhower R.C., and Kaufmann S.H. The current status of camptothecin analogues as antitumour agents. J. Natl. Cancer Inst. 85 (1993) 271-291
16. Martens A.C., van Bekkum D.W., and Hagenbeek A. The BN acute myelocytic leukaemia (BNML) (a rat model for studying human acute myelocytic leukaemia (AML)). Leukaemia 4 (1990) 241-257
17. Rollan Haro A.M., Smyth A., Hughes P., Reid C.N., and McHale A.P. Electro-sensitisation of mammalian cells and tissues to ultrasound: a novel treatment modality. Cancer Lett. 222 (2005) 49-55
18. Colombo L., Gonzalez G., Marshall G., Molina F.V., Soba A., Suarez C., and Turjanski P. Ion transport in tumors under electrochemical treatment: in vivo, in vitro and in silico modelling. Bioelectrochemistry 71 (2007) 223-232
19. Selvi B., Patel S., and Savva M. Physicochemical characterisation and membrane binding properties of camptothecin. J. Pharm. Sci. 97 (2008) 4379-4390
20. 18F] fluoroetanidazole as a new marker for imaging tumour hypoxia with positron emission tomography. Brit. J. Cancer 90 (2004) 2232-2242
21. Bratasz A., Pandian R.P., Deng Y., Petryakov S., Grecula J.C., Gupta N., and Kuppusamy P. In vivo imaging of changes in tumor oxygenation during growth and after treatment. Magn. Res. Med. 57 (2007) 950-959
22. Nordenstrom B.E.W., Eksborg S., and Beving H. Electrochemical treatment of cancer (II): effect of electrophoretic influence on adriamycin. Am. J. Clin. Oncol. 13 (1990) 75-88
23. Xin Y.L., Xue F.Z., Ge B.S., Zhao F.R., Shi B., and Zhang W. Electrochemical treatment of lung cancer. Bioelectromagnetics 18 (1997) 8-13
24. Okamoto I., Nishimura T., Miyazaki M., Yoshioka H., Kubo A., Takeda K., Ebi N., Sugawara S., Katakami N., Fukuoka M., and Nakagawa K. Phase II study of combination therapy with S-1 and irinotecan for advanced non-small cell lung cancer: West Japan thoracic oncology group 3505. Clin. Cancer Res. 14 (2008) 5250-5254
25. Koshkina N.V., Waldrep J.C., and Knight V. Camptothecins and lung cancer: improved delivery systems by aerosol. Curr. Cancer Drug Targets 3 (2003) 251-264